Status:
COMPLETED
Choroidal Thickness in Beta-thalassemia Patients
Lead Sponsor:
University Hospital of Patras
Conditions:
Beta-Thalassemia
Eligibility:
All Genders
18-85 years
Brief Summary
The purpose of this study is to examine choroidal thickness in beta-thalassemia patients and compare it to the one of healthy controls. An equal number of transfusion dependent beta-thalassemic patie...
Detailed Description
Beta thalassemia is an inherited hemoglobinopathy, associated with defective production of beta-chain globin resulting in problematic HbA production. It is classified according to the severity as mino...
Eligibility Criteria
Inclusion
- Beta thalassemia patients undergoing blood transfusions
Exclusion
- History of glaucoma, keratoconus, retinal disease, ocular trauma, ocular surgery, uveitis, amblyopia, strabismus, ocular vascular abnormalities
- Spherical refractive error greater than 4 diopters or cylindrical refractive error greater than 2 diopters
- History of other systemic disease such as uncontrolled hypertension, diabetes mellitus, or connective tissue disease.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04067258
Start Date
May 1 2019
End Date
April 1 2020
Last Update
June 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, General University Hospital of Patras
Pátrai, Achaea, Greece, GR26504